Market Exclusive

Analyst Downgrades – NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) Stock Gets Downgraded By LADENBURG THALM/SH SH from Buy ➝ Neutral to

Analyst Ratings For NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)

Today, NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) stock was downgraded by LADENBURG THALM/SH SH from Buy ➝ Neutral to with a price target of $26.54.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) has insider ownership of 45.80% and institutional ownership of 89.90%.

Recent Trading Activity for NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
Shares of NASDAQ:GHDX – Genomic Health closed the previous trading session at with 49.84000015258789 shares trading hands.

Exit mobile version